SNBNCBS develops a device for screening of bilirubin level in new born

▴ snbncbs-develops-no-touch-painless-device-non-invasive-screening-bilirubin-level
The operation of the device is based on non-contact and non-invasive spectrometry-based techniques for measurement of neonatal bilirubin level

Careful screening of bilirubin level in new-borns is mandatory as per American Academy of Paediatrics (2004), to reduce incidents of a type of brain damage called kernicterus that can result from high levels of bilirubin in a baby's blood. Although invasive capillary collection of blood and the subsequent biochemical test is considered a gold standard for jaundice detection in neonates, transcutaneous bilirubin measurement using non-invasive instruments has obvious added advantages.

The device called “AJO-Neo” is developed by Professor Samir K. Pal & his group at S.N. Bose National Centre For Basic Sciences (SNBNCBS), Kolkata, an autonomous research Institute under the Department of Science and Technology (DST), Government of India. The institute is also hosting one of the Technical Research Centres (TRC) funded by DST and in scientific collaboration with Nil-Ratan Sircar (NRS) Medical College and Hospital, Kolkata. The operation of the device is based on non-contact and non-invasive spectrometry-based techniques for measurement of neonatal bilirubin level as an alternative of total serum bilirubin (TSB) test without limitations of other available bilirubin meters.

According to the study conducted by the SNBNCBS team in NRS medical college, the newly developed device (AJO-Neo) is reliable in measuring bilirubin levels in preterm, and term neonates irrespective of gestational or postnatal age, sex, risk factors, feeding behavior or skin colour. The device is found to deliver an almost instantaneous report (about 10 seconds) to a concerned doctor, who is sitting 10000 km away from the point of care.

This is a significant achievement compared to the conventional “blood test” method, which may take more than 4 hours to generate the report. It has to be noted that detection of neonatal blood bilirubin (Hyperbilirubinemia) faster is extremely important for therapeutic management in order to avoid Kernicterus leading to Neuo-psychiatry problems in neonatal subjects. AJO-Neo also shows several advantages compared to other similar imported devices in the market.

The Technology has been transferred by the National Research Development Corporation (NRDC), an enterprise of DSIR, Ministry of Science and Technology, Government of India in the presence of Prof. Ashutosh Sharma, Secretary, DST to a Vijayawada based company, M/s Zyna Medtech Private Limited. Mr. Maninder Singh Lal, Chairman and Managing Director of the company, expressed satisfaction for getting opportunity to take part in the commercialization of Indian technology, which has the potential to rule the global market.

“Development of convenient, non-invasive diagnostics based on deep understanding of physicochemical sciences is happening at a faster pace around the world, and the institutions focused on basic sciences such as S.N. Bose National Centre For Basic Sciences at Kolkata, are thus compelling partners in technology and device development,” said Prof Ashutosh Sharma, Secretary, DST.

Tags : #SNBNCBS #ProfSamirKPal #AmericanAcademyofPaediatrics #NRDC #DST #ProfAshutoshSharma

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

August is Vision and Learning Month!August 08, 2020
Recovery Rate at 68% while CFR at 2.05% ; India Covid News Update Aug 8August 08, 2020
Meghalaya, Nagaland, Tripura, Mizoram COVID news update ; Aug 8 2020August 08, 2020
States, UTs to conduct Coronavirus tests of all grocery shop workers and street vendors August 08, 2020
Moderna signs up COVID Vaccine deal with Swiss government August 08, 2020
BMC makes home quarantine compulsory for domestic travellersAugust 08, 2020
Gujarat: COVID recovery rate reaches 75.04%, over 9.30 lakh tests conductedAugust 08, 2020
Serum Institute puts a ceiling of Rs 225 ,would produce 100 million doses of vaccineAugust 08, 2020
Indian Pharma on growth path, only hurdle, regulatory interventions ; PWCAugust 07, 2020
Karnataka: COVID-19 recovery rate improves to 50.73 pctAugust 07, 2020
Maharashtra: Phase-two clinical trials of Covaxin for Covid-19 to begin from Aug 10August 07, 2020
Pankajakasthuri Herbal completes successful trial of ZingiVir-HAugust 07, 2020
Obesity reduces blood flow to the brain, increasing risk to Alzheimer's diseaseAugust 07, 2020
What Is The Ideal COVID-19 Response? These 3 Countries Got It RightAugust 07, 2020
WHO sends experts to South Africa to help fight virusAugust 07, 2020
More European Nations Tighten Virus Curbs As Global COVID-19 Deaths Top 7 LakhAugust 07, 2020
UK Reimposes Quarantine For Travellers From Belgium, Bahamas Over Spike In CasesAugust 07, 2020
Govt proposes to launch National Clinical Registry for data collectionAugust 07, 2020
France, Belgium Covid-19 Cases Rising FastAugust 07, 2020
COVID-19 claims 67 additional lives in IraqAugust 07, 2020